Gainers

• Aethlon Medical (NASDAQ:AEMD) shares increased by 382.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $1.0 million.
• Akanda (NASDAQ:AKAN) stock rose 15.07% to $3.13. The company's market cap stands at $1.4 million.
• Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 13.41% to $3.55. The market value of their outstanding shares is at $1.8 million.
• Tiziana Life Sciences (NASDAQ:TLSA) stock moved upwards by 12.97% to $0.87. The company's market cap stands at $97.9 million.
• bioAffinity Technologies (NASDAQ:BIAF) shares increased by 11.4% to $5.96. The market value of their outstanding shares is at $3.2 million.
• Brookdale Senior Living (NYSE:BKD) shares increased by 11.39% to $13.0. The company's market cap stands at $2.7 billion.

Losers

• Longeveron (NASDAQ:LGVN) shares fell 55.0% to $3.01 during Thursday's pre-market session. The company's market cap stands at $21.2 million.
• Q/C Technologies (NASDAQ:QCLS) stock fell 13.87% to $0.83. The company's market cap stands at $7.8 million.
• Bone Biologics (NASDAQ:BBLG) stock decreased by 12.56% to $0.47. The market value of their outstanding shares is at $1.4 million.
• Tempest Therapeutics (NASDAQ:TPST) stock decreased by 10.75% to $1.08. The company's market cap stands at $20.0 million.
• Biodexa Pharmaceuticals (NASDAQ:BDRX) stock decreased by 10.42% to $0.86. As per the news, the H1 earnings report came out 4 days ago.
• Bio Green Med Solution (NASDAQ:BGMS) shares declined by 7.16% to $0.92. The company's market cap stands at $6.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.